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ABSTRACT

The effects of farm use or exclusion of antibiotics on antibiotic resistance
patterns of bacteria were compared using fecal samples from live swine. Four farms
that used antibiotics and three farms that excluded antibiotics from production were
selected and from each farm, 6 pigs from each of 4 weight groups (4.5 , 23, 45, and
109 kg) and 5 sows were randomly selected for collection of fecal samples. E. coli,
O157:H7 E. coli, and Salmonella spp. were isolated from fecal samples and tested for
sensitivity to gentamicin, sulfamethazine, oxytetracycline, ceftiofur, and ampicillin
using a standardized minimum inhibitory concentration (MIC) analysis. Resistance
patterns were markedly different between farm types in E. coli, and moderately so in

Salmonella. In both cases, isolates from farms that excluded antibiotics had lower (P
< 0.05) MI Cs. The number of resistant isolates and those that demonstrated multiple
resistance patterns was greater (P < 0.05) on farms that used antibiotics. E. coli from
farms that excluded antibiotics had significantly lower (P < 0.001) MICs for
gentamicin, sulfamethazine, oxytetracycline, and ampicillin and lower (P < 0.10)
MICs for ceftiofur. Farm type differences were most evident for isolates from
younger pigs for gentamicin, ceftiofur, and ampicillin but were also noted among all
pig groups for sulfamethazine and oxytetracycline. In Salmonella, the MI Cs were
higher from farms that used antibiotics particularly for oxytetracycline and ceftiofur (P

< 0.001). O157:H7 E. coli were isolated from 2 farms, both of which used antibiotics
in production, thus a relevant analysis on that bacterium was not possible. In total,
lll

these data indicate that exclusion of antibiotics in swine production decreases
antibiotic resistance in E. coli, and to a lesser extent resistance in salmonellae.
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1. INTRODUCTION

In the United States less than 2% of the population is directly involved in
producing food for retail trade. Changes in the food animal industry are responsible in
part for the gradual reduction in number of traditional farms. In the food animal
industry there has been a move away from individual farms and toward more intensive
or integrated animal production systems. These close confinement type operations
reduce input of land, feed, and labor and maximize output of lean, healthy high quality
animals (NRC 1999). The success of this transition in animal production may be
partly due to the use of antibiotics. Antibiotics not only prevent and control diseases
that might otherwise rapidly overwhelm densely populated groups of animals, but also
increase the rate of growth and improve feed conversion efficiency.
The benefits provided by antibiotic use in animals brings with it new
challenges in meeting the increasing demands (more high quality meat) and
expectations (limited risk of contaminants such as antibiotic resistant bacteria) of the
consuming public. A survey conducted by the Economic Research Service (ERS
1994) of the United States Department of Agriculture (USDA) revealed that out of all
of the food safety issues, concern about pathogens in food was the issue most
frequently cited during the period of 1937 to 1991 in news and media data bases. The
issue of agricultural use of antibiotics and the evolution and transfer of antibiotic
resistant bacteria has caused some segments of the medical community and consumer
groups to suggest that antibiotics used in human medicine should not be used on
animals, or that subtherapeutic use of antibiotics (low dose prophylaxis and growth

promoting amounts) should be banned. Decisive legislation concerning the use of
antibiotics in food animal production and the threat to human medicine has been
hindered by the lack of data with regard to cause and effect relationships between
antibiotics and resistant bacteria. In the pork industry, for example, little is known
about how either of the above mentioned recommendations will influence the amount
of foodbome pathogens or more importantly resistant foodbome pathogens in market
weight pigs and subsequent pork products. Some of the more recent drugs used in
swine production have yet to be consistently monitored using standardized methods.
New drugs provide an excellent opportunity for tracking the progression of antibiotic
resistance through various pork production management schemes. This information
could be used to devise efficient strategies that would prolong the efficacy of the
antibiotics against pathogens while limiting the risk of inducing resistance. The
purpose of this study was to determine if differences in antibiotic resistance patterns
occur between bacteria isolated from swine produced on farms that have used old and
new antibiotics versus farms that excluded antibiotics.
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1. LITERATURE REVIEW

Domagk discovered the antibacterial action of sulfonamides in 1935 (Visek
1978). Experiments with these drugs caused depressed growth (Black et al. 1941 ;
Kornberg et al. 1943) and vitamin deficiency signs in rats. These adverse effects were
reversed with dietary supplementation offolic acid (Daft and Sebrell 1943) or biotin

(Daft et al. 1942). It was then recognized that intestinal bacteria had the ability to
synthesize vitamins (Elvehjem 1948) and be beneficial to the host unless they were
pathogenic. Martin (1942) was the first to recognize that sulfonamides given to rats
with infectious diseases increased survival rate and growth (Visek 1978). The
potential for increasing the growth rate of farm animals with antibiotic agents was first
suggested by Moore et al. (1946) and Morehouse and Mayfield (1946). The growth
stimulation effect of antibiotics became fully appreciated during a search by Dugger
(1948) for a microbial source of vitamin B 12 from Streptomyces aureofaciens.
Researchers at Lederle Laboratories found that something other than Dugger' s B12 was
causing what now is known as the antibiotic growth effect (CAST 1981 ).
The economic benefits (NRC 1999) brought about by antibiotic growth
promotion have become the principal reason for the use of antibiotics in food animal
production (Hays 1986). Antibiotics used at low (subtherapeutic) levels increase
animal gains with less feed, and help prevent disease (Hays 1969; CAST 1981;
Zimmerman 1986; NRC 1999). Subtherapeutic use is defined in the United States as
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the use of an antibiotic as a feed additive at less than 200 g per ton of feed (NRC
1999). Eighty percent of the antibiotic drugs used in livestock and poultry are used at
subtherapeutic concentrations (IOM 1989). In the U.S., nearly 100% of the chickens
and turkeys, 90% of the swine and veal, 60% of the feedlot cattle, and 75% of dairy
calves are fed antibiotics at some time during their lives (CAST 1981; Manchanda
1994).
Hog performance is improved with the use of subtherapeutic concentrations
(NRC 1999). In hogs, antibiotics are used in about 90% of starter feeds, 75% of
grower feeds and in more than 50% of the finisher feeds and in at least 20% of sow
feeds (NRC 1999). It is estimated that the average increases in rates of gain for pigs
from the use of antibacterials in their starter, grower and finisher feeds are about 25,
15, and 16% respectively. Corresponding estimates for feed utilization improvement
are 9, 5, and 3% (Braude et al. 1953; Hays 1977). In breeding animals, feed-additive
antibiotic drugs improve farrowing rate, litter size (Hays 1977), birth weight, and
number of pigs weaned per litter (Hays 1986; NRC 1999). Stahly (1995) notes "In
addition to enhancing pig performance, subtherapeutic concentrations of
antimicrobials may also alter lean tissue growth." Others have made similar assertions
(Hathaway 1990; Roth and Kirchgessner 1990).
Responses to antibiotics are much greater in young pigs (Hays 1969) and then
decline as the animals mature (Hays 1985). Other factors that may affect an animal's
response to antibiotics are the animal's genetic predisposition (Stahly 1996), the status
of the pig's immune system (van den Broeck 1993), and the type and duration of
4

antibiotics used (Fagerberg et al.1979). For instance, agents that are widely
distributed in the body and have a broad spectrum of antibacterial activity produce a
greater growth response (Visek 1978). Responses may also vary with the type of
carbohydrate in the diet (Stokstad et al. 1953; Harbers 1963) and changes in the diet
(Schaedler and Dubos 1959).
The FDA has approved twenty-nine drugs (21 antibiotics and 8
chemotherapeutics) for use in hogs (Shepard et al.1992). To improve growth rate in
hogs, 10 antibiotics (of microbial origin) and 2 chemotherapeutics drugs are used.
The 10 antibiotics are arsenilic acid, bacitracin, bambermycins, chlortetracycline,
efrotomycin, oleandomycin, penicillin, tiamulin, tylosin, virginiamycin, and the 2
chemotherapeutics are arsanilic acid and carbadox (NRC 1999). Avilamycin
(MaxusR) adds to the list of hog growth promotants (Roth and Kirchgessner 1993).
The following are prophylaxes: arsenilic acid, bacitracin, chlortetracycline,
tiamulin, tylosin, and carbadox. Others that are approved for therapeutic use but not
as growth promotants are antibiotics, amoxicillin, ampicillin, apramycin,
erythromycin, gentamicin, lincomycin, neomycin, oxytetracycline, spectinomycin,
streptomycin, tetracycline; and chemotherapeutics, aranilate sodium, roxarsone,
sulfaethoxypryidazine, sulfachlorpydazene, sulfamethazine, and sulfathiazole (NRC
1999).
Antibiotic substances presently used in animal production fall into two broad
groupings: broad and narrow spectrum antibiotics (Hays 1986) and (Merck Veterinary
Manual 1986; Kucers et al., 1997). Broad-spectrum antibiotics such as :3-lactams
5

prevent proper formation of bacteria cell wall making them generally effective in
killing a wide range of bacteria. Narrow-spectrum drugs are usually highly selective
by targeting biochemical pathways specific to a particular species of bacteria (NRC
1999).
Antibiotic action against bacteria varies among drug groups. Bactericidal
drugs kill invading organisms (Merck Veterinary Manual 1986; Kucers et al. 1997).
Bacteriostatic drugs prevent the growth of organisms, but do not kill them directly
(NRC 1999).
Antibiotics are also classified as to how they are absorbed and their mode of
action against microorganisms. Systemic antibiotics are absorbed in the intestines in
large amounts. They include the tetracyclines (chlortetracycline, oxytetracycline, and
tetracycline), erythromycin, lincomycin, and penicillin (procaine). N onsystemic
antibiotics are not absorbed from the intestines in significant amounts. This group
includes bacitracin (zinc, manganese, or methylene disalicylate), neomycin sulfate,
streptomycin chloride or sulfate, tylosin, oleandomycin, novobiocin, virginiamycin,
and bambermycins (CAST 1981 ).
The exact mode of action of antibiotics in bringing about growth promotion is
not thoroughly understood. Cromwell (1991) has summarized three possibilities. The
first involves direct biochemical events that are affected by antibiotics: decreased
nitrogen excretion (Roth and Kirchgessner 1993), efficiency of phosphorylation
reactions in cells, and direct effects on protein synthesis (V ervaeke et al. 1979). The
second involves direct effects on metabolism, including the effects of antibiotics on
6

the generation of essential vitamins and cofactors by intestinal microbes and the way
that antibiotics affect the population of microbes that make these nutrients. In
addition, the feeding of antibiotics is associated with decreased gut mass (Pepper
1953; Milner and Visek 1974), increased intestinal absorption of nutrients, and energy
sparing. This reduces the nutrient cost for maintenance, so that a larger portion of
consumed nutrients can be used for growth and production, thereby improving the
efficiency of nutrient use for productive functions (Okumura et al.1978 ; Visek 1978).
The third proposed mechanism of action is eliminating subclinical populations of
pathogenic microorganisms (NRC 1999). This can be achieved with bactericidal
drugs or subtherapeutic concentrations of antibiotics that increase specific
immunological responses of the host to invading bacteria (Easmon and Desmond
1982; Veringa and Verhoef 1985; Hand et al. 1989).
Resistance of microorganisms to antibiotics develops through several
mechanisms (reviewed in Davies and Webb 1998; Hickey and Nelson 1997; O'Grady
et al. 1997). For instance, an alteration of the target for the antibiotic can protect the
microbe from the drug by removing its substrate. Microbes can develop the enzymatic
capability to degrade a drug, develop a mechanism to pump the drug out of the cell or
develop an altered uptake system to prevent drug entry. Cells can also lose their ability
to metabolize the drug into the actual inhibitory compound. Bacteria are known to
retain defenses against antibiotics, such as tetracycline, that have been discontinued in
a swine operation for 13 years (Langlois et al. 1986). In some of these cases
compensatory mutations are linked to the drug resistant gene in such a way that
7

reversion to susceptibility would be cidal. The bacteria must retain the resistance to
remain viable.
Some bacteria are "naturally resistant". For instance, penicillin does not work
against salmonella (AHI 1998). Resistant bacteria have been isolated from apparently
nonselective environments (Mach and Grimes 1982; Levy 1992). Normally, in a "wild
type" bacterial population, approximately 2% are resistant to any given antibiotic
(Novick 1981). Sometimes, by chance, bacterial genes mutate and as a result a viable
resistant strain of bacteria will emerge. More commonly, resistance emerges through
selective pressure applied through exposure to antibiotics. The most resistant bacteria
are usually found in environments with the highest levels of antimicrobials such as
hospitals (Datta 1969), fish farms (Sandaa et al. 1992), sewage, and wastewater
(Fontaine and Hoadley 1976).
In animals and humans, conventional indigenous microflora prohibit the
establishment of invading enteric pathogens by competitive exclusion (Dubos and
Shaedler 1960, 1962; Hentges 1969). In the bowel of humans and animals there are
more than 10 10 bacteria per gram of feces. Most belong to a heterogeneous group of
Gram-negative bacilli, called enteric bacilli the most abundant of which are the
anaerobes Clostridium and Bacteroides (Anderson 1975). When subjected to
prolonged or high doses of antibiotics, these commensal bacteria are killed or inhibited
along with the pathogenic ones and resistant bacteria multiply to take their place
(Gordon et al. 1959; Kobland et al. 1987).
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Antibiotic resistance is the ability of certain bacteria, which are normally
destroyed by a particular antibiotic, to survive exposure to that antibiotic. Resistance
means that the bacteria no longer respond to the treatment. Susceptibility describes
how sensitive bacteria are to antibiotics (AHI 1998).
Once resistance occurs through a mutational event, bacterial resistance can
spread. Chromosomal resistance can be transferred to the progeny (Piddock
1996), or R (resistant) plasmids can be transferred from one bacterium to another
(Hickey and Nelson 1997). Transferable resistance via R plasmids, the more common
form, was first recognized by Japanese investigators (Watanabe 1963). R plasmids can
spread among bacterial strains within species and between genera (Frieden et al.
1993), even under simulated natural conditions in the absence of antimicrobial agents
(Kruse and SNrum 1994).
There are several mechanisms of plasmid transfer. Bacteria can engulf free
DNA from dead cells through a process called transformation. A form of sexual
transfer (conjugation) of genetic material by way of a narrow tube (pili) can also take
place. Transduction is a phage (bacterial or viral) mediated transfer of genetic
material. In addition, transposons, a class of DNA genes, can be shuttled between
plasmids and chromosomal DNA (NRC 1999).
Resistance to one antibiotic may be genetically linked to resistance to one or
more other antibiotics (CAST 1981 ; Hays 1986). Resistant organisms can accumulate
resistance elements by which they become multi-drug-resistant. Resistance to

9

multiple agents is often encoded on a single plasmid, transposon, or integron and can
be acquired en bloc (Murray 1994).
The time between introduction of an antibiotic and development of resistance
is becoming shorter. This may be due to greater use of newer antibiotics (Mathew et

al. , 1998), and also to the fact that bacteria can now more easily modify existing drug
resistance mechanisms rather than create mechanisms de novo, as was the case when
antibiotics were first introduced (Tomasz 1994; Mathew et al. , 1998).
It has been suggested but, with conflicting evidence, that plasmids which
confer resistance affect the pathogenicity of organisms (Jarolmen 1971 ; Smith 1972).
For instance, an R plasmid may also carry a gene for production of enterotoxin (Gyles
et al. 1977; Hays 1986; Smith and Fatamico 1995).
A number of bacterial diseases of animals are transmissible to humans
(zoonotic). It is of concern that either resistant bacteria may be capable of causing
human disease that cannot be treated because the pathogens will be resistant to the
drugs indicated for treatment (Levy 1992; Piddock 1996) or that non-pathogenic
organisms could transmit their R plasmids to human flora or pathogens with the same
results (Gyles et al. 1977; Levy 1992). The possible relationship between antibiotic
resistance in the enteric flora of food producing animals and antimicrobial efficacy in
the treatment of infections in humans has been studied over the past 50 years.
Comprehensive discussion of antibiotic resistance and associated risks began with
Great Britain' s Neatherthorpe and Swann Committees and continued in the United
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States by task forces of the FDA, various councils, and on two occasions by the
National Academy of Sciences (Donnelly et al. 1996).
Case studies have shown that the passage of resistant organisms from animals
to humans can occur and be perpetuated and amplified through food (Spika et al.
1987). Transfer ofR plasmids among bacteria from animals to humans has been
demonstrated (Smith, 1969, 1970, 1972; Jarolmen 1971; Levy et al. 1976; Levy 1978).
However, the transfer does not take place as rapidly in vivo as it dies in vitro (Falkow
1975), possibly due to interference by normal gut flora (Anderson 1975).
The Institute of Medicine (IOM 1989) and the Office of Technology
Assessment (OTA 1995) have reported on circumstantial evidence linking
subtherapeutic use of antibiotic drugs in farm animals to potential human health
hazards. The Institute of Medicine reported that the absolute number of antibioticresistant isolate bacteria appears to be greater when subtherapeutic doses are used in
animal feed than when therapeutic doses are given (IOM 1989). Walton (1986)
contends that antibiotic concentrations achieved in animals fed antibiotics at many of
the subtherapeutic concentrations used in the field do not reach concentrations
necessary for the selection of resistant strains. At least one experiment has shown that
feeding therapeutic levels of chlortetracycline for 14 days increased antibiotic
resistance and multiple antibiotic resistance more than the feeding of subtherapeutic
chlortetracycline for 85 days (Langlois 1983). Experimenters that compared the
antibiotic resistance of Gram-negative fecal bacteria from pigs in three herds with
different histories of antibiotic exposure concluded that any form of antimicrobial
11

exposure would increase that prevalence of antimicrobial resistance and multiple
resistance of fecal bacteria (Dupont and Steele 1987; Gellin et al. 1989).
Some scientists support the opinion that antibiotics used in food-animals are
fundamentally benign to human health (Frappaolo 1986; van den Bogaard 1993).
Others have pointed out that both fruits and vegetables (Levy 1984) have been
associated with resistant bacteria, as well as animal protein. Statistics from the
Department of Agriculture show that animal carcasses inspected just after slaughter
have very low levels of contamination, which suggests that antibiotic use may be a
factor in keeping bacteria counts low (AHI 1998). In a May 1999 interview, John
Keeling, vice president of legislative and public affairs for the Animal Health Institute,
offered the following quote " There is no documented case where antibiotic use in
animals has caused treatment failure in people" (Ishmael 1999).
It has been shown that factors other than exposure to subtherapeutic or
therapeutic antimicrobials may be responsible for increases in pathogens and
antimicrobial-resistant enteric bacteria in animals (Bolder and Mulder 1983; Dawson
et al 1984; Langlois et al. 1986; Stern 1995). In swine, dirty quarters, stress of
transport (Embry et al. 1962, 1966, 1969), overcrowding in holding pens, rough
handling before slaughter (Williams and Newell 1970; Corrier et al. 1990), decreases
in temperature (Moro et al.1998), and feed and water removal (Bierer and Eleazer
1965; Smith 1977) have been reported to increase shedding of Salmonella sp.
(Williams and Newell 1970; Rigby and Pettit 1980; Corrier et al. 1990),

Campylobacter spp. (Stern and Line 1992; Jacobs-Reitsma et al. 1994) and E. coli
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0157 :H7 (Rasmussen et al., 1993 ), as well as the percentage of antimicrobial-resistant
enteric bacteria shed into the environment (Molitoris et al. 1987), even in herds that
have not been exposed to those drugs in over 13 years (Langlois et al. 1986; Dawson
et al. 1984). These external factors upset the equilibrium of the intestinal function and
flora lowering the resistance of otherwise healthy animals to pathogens (Mulder
1995). Pathogens that are orally consumed before and during crating and
transportation may colonize the ceca where they may be retained throughout
processing (Moran and Bilgili 1990).
Abuse of antibiotics is common in human medicine and also contributes to the
pool ofresistant bacteria (IOM 1989 and 1998; Amabile-Cuevas 1993; Hickey and
Nelson 1997). At least half of the antibiotics prescribed in the United States are
unnecessary or inappropriate according to Levy (1998). In many cases the antibiotics
suggested are not specific to the infectious organisms or the recommended dosage and
duration are wrong (CDC 1994; IOM 1998).
Conversely, data from the United States National Swine Survey collected by
the National Animal Health Monitoring System were used to describe the use of feed
additives in swine feeds. Of 3,328 feeds tested, only about of the 21 % of the feeds
contained additives in an off-label manner. One-half of these included greater
concentrations of antibiotics than recommended or the wrong age of pigs were treated
and the other half consisted of off-label combinations (Dewey et al. 1997).
Once a resistant human pathogen emerges, there are many factors that can
contribute to its proliferation. Foremost is the density and mobility of the human
13

population. The increasing population, particularly of elderly and
imrnunocompromised individuals, may provide greater opportunity for resistant
pathogens to persist (Telzak et al. 1991). There have also been dramatic changes in
consumer eating habits and the methods in which food is provided.
People are eating more frequently in restaurants and institutional cafeterias,
increasing their contact with and exposure to one another. In addition food is
produced, processed, handled and prepared in ways that concentrates activities to
fewer and larger companies with extensive distribution capabilities (CDC 1994). All
of these factors contribute to the spread of resistant organisms. The transfer of
resistant organisms can take place whenever the conditions are right for bacterial
growth (Hays 1986).
Research has shown that consumers are more sensitive to the subject of
pathogens in food than any other food safety issue (ERS 1994). Technological
advances in detection, surveillance and reporting have improved our ability to isolate
and identify "new" pathogens or recognize foodbome diseases, formerly classified as
cause "unknown" which may contribute to our perception of their increasing
emergence (Smith and Fratamico 1995; NRC 1999). Not all reports accurately reflect
the current status of the problem. For example, collection, analysis, and measurement
of farm animal samples are not standardized in many studies and what information
does exist cannot be pooled. By contrast, data on bacterial resistance in humans are of
higher quality and are now on-line and widely available for many types of
sophisticated analyses (AHi 1998). Others find the inherent problems of the tests of
14

antibiotic sensitivity and inconsistent interpretations of the results to be problematic
(Wiedmann 1993). For example, the definition of resistance varies between countries
as determined by minimwn inhibitory concentration analysis. For ampicillin,
resistance is determined in E .coli as~ 2,

4,

8, and~ 16 :g/mL for Sweden,

Germany, the Netherlands, and the United States, respectively (Wiedmann 1993).
Some of the most important pathogens that have emerged lately that are
frequently associated with food animals are, Eschericia coli O157:H7, a virulent strain
not known to be resistant to antibiotics, vancomycin-resistant enterococci a pathogen
resistant only to antibiotics used in hwnan medicine, and Salmonella DT-104, a multiresistant strain that has been linked to the use of antibiotics in food animals but still
sensitive to some hwnan therapeutics.
Escherichia coli O157:H7 which causes hemorrhagic colitis and hemolytic
uremic syndrome: is an E. coli strain with increased virulence that has caused a
nwnber of fatalities in foodbome outbreaks (Smith and Fratamico 1975). This new E.
coli serotype is believed to have evolved in Central America in the 1980s. It became
pathogenic through the acquisition of virulence factors from a type of Shigella
bacteriwn that causes severe dysentery in humans. Shigella is not found in animals
(AHi 1998). The organism has the ability to adhere intimately to intestinal cells by an
attaching and effacing mechanism and produces one or more types of phage-encoded
Shiga-like toxins (Smith and Fratamico 1975). To date, this pathogen has not been
implicated in antibiotic resistance problems and the most frequent outbreaks have been
associated with vegetable and fruit juices rather than animal protein (NRC 1999).
15

There have been attempts to establish a possible link between the appearance
of vancomycin-resistant enterococci (VRE) in humans and the food chain. Donnelly et
al. (1996) point out that the Van A gene may have spread from humans to farm
animals. V ancomycin belongs to the glycopeptide family of antibiotics along with
avoparcin. A voparcin has been used in the European Community as a growth
promoter in animal feeds (Bates 1997). However, VRE has also appeared in the
United States where avoparcin is only used for human medicine (Bingen et al. 1991 ;
Frieden et al. 1993; Bates 1997). Vancomycin use has been on the rise for patients
having major cardiovascular (Maki et al. 1992), orthopedic, and organ transplant
surgeries, or low birth weight infants (Payne et al. 1994). The increased role of
vancomycin as a defensive medicine may have attributed to intense selection pressure
and rapid escalation in VRE (Hays 1996). In areas of the world where glycopeptides
are used in animals, VRE is ten-fold less common, if it is present at all (Hayes 1996).
The increase in VRE occurred in the USA in the absence of any use of glycopeptide
antibiotics in animals (Hayes 1996). In North America, broad-spectrum tetracyclines,
ionophores, and bacitracins continue to be the dominant feed additive antibiotics used
on poultry and livestock (Donnelly et al. 1996).
The 5-drug-resistant (ampicillin, chloramphenicol, streptomycin, sulfonamide,
and tetracycline) Salmonella (definitive type DT-104) is an isolate that is now
reportedly resistant to ciprofloxin, the fluoroquinolone used in humans. Again,
differences in terminology and measurement techniques may have confounded this
issue. Whether or not this strain is resistant to ciprofloxin depends upon individual
16

definitions of resistance (NRC 1999). This strain appeared more than year before
fluoroquinolones were actually used in animal production in the United Kingdom, and
almost a decade before their use in poultry (1994) and cattle (1998) in the United
States (AHI 1998). In the United States, a surveillance board named "National
Surveillance for Antibiotic Resistance in Zoonotic Enteric Pathogens" has been
established to track and oversee the effect of antibiotics in the development of resistant
bacteria and to determine further use of these antibiotics in food animals. Surveillance
data reviewed by FDA and CDC experts stated that, at the time of the report, there
were no isolates of Samonella DT-104 that were resistant to ciprofloxacin in the
United States (Glynn et al. 1998).
In the past, the common response to resistance has been to develop new
classes of antimicrobials (Ishmael 1999). However, in a 1991 survey of
pharmaceutical companies in the United States and Japan, 50 percent reported that
they had substantially reduced or abandoned antibacterial research because the market
for antibiotics was saturated. It is estimated that it takes several years to bring a new
food animal drug to market (CAST 1981). Only 1 compound in 7,500 tested for initial
activity reaches the market (AHI 1993). With the estimated investment of more than
$300 million required to bring a new antibiotic to market, there is little incentive for
such endeavors (Murray 1994).
Overall, the yearly cost exacted by drug-resistant infections in the United
States is estimated to exceed $30 billion (Radetsky 1998). Public health community
concerns are that antibiotics are approved for the use in animals before their efficacy
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against human illnesses has been exhausted, thus speeding up the development of
resistance. Many believe that antibiotics that are used in humans should not be used in
animals, and this was one of the recommendations of the Swann Committee in 1969
(NRC 1999; Swann 1969). However, follow-up tests have shown that different drugs
from the same antibiotic class used in animals and humans leads to cross-resistance
because bacteria are unable to distinguish between the two (Piddock 1996). In
addition, a single drug can select resistance to several chemically unrelated agents
(Piddock 1996).
Another recommendation of the Swann Committee was to restrict the use of
antibiotics to a prescription only basis. This failed to influence the amount of
antibiotics used in England, because some larger producers employ their own
veterinarians (CAST 1981). World Health Organization (WHO 1997) is in favor of
phasing out the use of antibiotics; particularly penicillin, tetracyclines, and others used
to treat human diseases. However, from experiments on the withdrawal of tetracycline
and penicillin, it does not appear that total restriction has an impressive influence on
reducing the level of resistant bacteria either. The level of tetracycline resistant fecal
coliforms in a 13 year, antibiotic-free herd declined from above 90% but the resistance
level is still between 20 and 55% without antibiotics and 5 generation turnovers of the
herd (Hays 1986).
Some critics (WHO 1997; Witte 1998) of current commercial production
methods suggest that antibiotics are necessary only because of the stressful rearing
conditions, and that the return to smaller individual farms would obviate the need for
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antibiotics (CAST 1981; Hays 1986; Roura et al. 1992). However, returning to that
type of animal rearing could result in environmental extremes, more exposure to
parasites and the associated susceptibility to diseases, and ultimately, an increase in
therapeutic use (Braude 1978; Hays 1986). The use of antibiotics has resulted in a
healthier animal population with fewer parasites and diseases. In addition, animal
welfare is improved and the environment benefits as well (Roth and Kirchgessner
1993 ; Donnelly et al. 1996). Food can be produced on fewer acres. Feed additives
reduce nitrogen excretion due to a more efficient utilization of the feed in pigs (Roth
and Kirchgessner 1993). Few people agree that the return to individual farms would be
a justifiable solution at this point.
Since the beginning of the use of antibiotics in feed, the average enhancement
in rate of growth appears to have remained relatively constant (Peo 1962; Teague et al.
1966; Visek 1978). Thus, either the mechanisms of growth promotion are unrelated to
antimicrobial factors or factors causing antibiotic resistance (Visek 1978; CAST 1981;
NRC 1999), or this observation is an illusion masked by the use of newer antibiotics
(Mathew 2000 personal communication). Whatever the case may be, more people
seem to be in agreement that the solution lies with development of new drugs or the
use of alternative growth promotants.
Chopra et al. (1996) have reviewed the search for antimicrobials effective
against multiple resistant bacteria. The development of new prophylactic and
therapeutic procedures discussed include the design of analogs of existing antibiotics
that resist enzymatic inactivation by bacteria, analogs that disable or elude recognition
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by bacterial efflux pumps, and analogs that inhibit protein synthesis on ribosomes that
express resistance to older tetracyclines. Novel antibiotics that specifically target
products associated with infection in vivo appear to hold the most promise. These
drugs target infection processes and will be highly specific for each pathogen and less
disruptive to the commensal flora. In order for these to be used effectively, more rapid
and accurate microbial diagnostics than are now available will have to be invented.
Other research has focused on alternatives to antibiotics. Copper was found to
be useful as both a growth promotant and an antibacterial (at higher levels) (Sollman
1957). However, multiple-antibiotic resistance (MAR) was linked with metal
tolerance in a study by Calomiris et al. (1984). They reported that simultaneous
selection for metal and antibiotic resistance might occur in some microorganisms.
Positive correlations between copper, lead and zinc tolerance and MAR were found
(Kunkle et al 1981 ; Kelley et al. 1996). Some analysts have predicted that substitutes
like these will also fall under regulatory scrutiny and possibly be banned (Edwards
1972).
Given the time and difficulties involved in research and bringing new
antimicrobials or growth promotants to market, the food animal industry has initiated
its own quality assurance programs to address consumer concerns and to improve
accountability of antibiotic use by producers. For instance, in the swine industry,
The National Pork Producers Council developed the Pork Quality Assurance Program
(PQA) (NPPC 1997). It is a 3 level, 10 step voluntary program to help producers
understand appropriate uses of medications. The program applies principles from the
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Hazard Analysis and Critical Control Points (HACCP) to the production of pork to aid
producers in monitoring and controlling farm drug use problems by identifying 10
critical control points. The PQA program was originally intended to reduce the
incidence of drug residues in meat, which is rarely a concern anymore but it is equally
effective in the control of the diseases and reducing the incidence of resistant
organisms.
The PQA program is practical for all types of pork production facilities, even those
that raise hogs organically. For a growing number of farmers, organic production is
becoming an increasingly viable alternative to traditional and industrial farming.
Producers are motivated to "go organic" for a number of reasons. Some enjoy the
challenge and opportunities of competing in new market. Market analysts have
reported that the organic industry has grown by 20% per year in the last five years
(Carter 1999). For others, the motivation is provided through financial incentives.
Organic products fetch premium prices in specialty markets and demand often exceeds
supply. In the United Kingdom, the Ministry of Agriculture has set up the Organic
Aid Scheme to provide financial assistance to farmers converting to organic methods.
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3. MATERIALS AND METHODS
Animals: Seven swine farms from the United States were selected to study the

effects of use or exclusion of antibiotics on antibiotic resistance patterns in
bacteria. Producers were interviewed to determine the history of antimicrobial
drug utilization within their herds. Three farms (Iowa, Kentucky, New Jersey)
excluded antibiotics in their production. Four farms (2 in Tennessee and 2 in
Indiana) used antibiotics in both subtherapeutic and therapeutic amounts.
Antibiotic use on the latter farms was documented for a minimum of 12 months
prior to the initiation of the study (Table 1). All farms were at least 62 km apart
except for the two farms in Indiana.
Sample Collection: At each farm, 6 pigs from each of 4 weight groups (4.5, 23,

45, and 109 kg) and 5 sows were randomly selected for collection of fecal
samples. Sterile dacron-tipped swabs were used to collect rectal fecal samples
from pigs by their owners. The swabs were placed in disposable screw cap vials
(16 x 125 mm, Fisherbrand®Fisher Scientific Company, Pittsburgh, PA) filled
with Cary-Blair transport medium (BAM 1995) and shipped immediately on ice in
coolers to the Dept. of Animal Science at the University of Tennessee, Knoxville.
Ground pork from one market weight pig from each farm was also sent by way of
an iced cooler. All samples were received at the laboratory within 48 hours of
collection.
Microbiological Procedures: The tips of the swabs were cut off into individual

sterile plastic tubes containing 5 mL of cryoprotectant, a freezer storage solution
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containing 10% sterile, inactivated horse serum, 20% sterile glycerol, and 70%
sterile trypticase soy broth. The contents were mixed by vortexing and divided into
5, 1 mL aliquots then stored at-80° C until used. One dacron-tipped swab was
used to swab the surface of the ground pork samples and was also inserted about
an inch into the ground pork. The swabs were in contact with the meat for about
30 seconds then placed in cryoprotectant solution as above.
Isolation of microorganisms: All cultivation media were prepared without the

use of antibiotics to prevent possible selection for resistant organisms. One
exception was made with Modified Trypticase Soy Broth (mTSB) an enrichment
broth containing novobiocin, recommended for the recovery of E. coli 0157
(BAM 1998).
Isolation ofE. coli: For the isolation of E. coli, a 1 mL aliquot of each sample

was thawed at room temperature and incubated at 37° C for 24 hours in 5 mL of
Mueller Hinton Broth (MH, BBL, Becton Dickinson and Company, Cockeysville,
MD). One loopful of the culture was streaked for isolation onto MacConkey II
MUG agar (MAC II, BBL, Becton Dickinson Microbiology Systems,
Cockeysville, MD) and incubated at 44° C for 24 hours. A control E. coli plate
was also streaked (ATCC 25922, American Type Culture Collection, Rockville,
MD).

MAC II agar contains bile salts to inhibit Gram positive organisms, a neutral
red pH indicator and MUG (4-methylumbelliferyl-B-D-glucoronide) for
presumptive identification of E. coli and differentiation between E. coli and E. coli
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0157: H7. E. coli metabolize lactose in this agar which reduces the pH causing
the indicator to turn pink. In addition, E. coli are characterized by production of 13D-glucoronidase an enzyme which hydrolizes MUG to yield 4methylumbelliferone, a compound which fluoresces blue-green under long-wave
(366) UV light. E. coli 0157:H7 do not produce this enzyme, so they are pink but
do not fluoresce. MAC II agar had a two-fold purpose, not only did it have 2
indicator ingredients for E. coli which prevented extra labor in further
confirmation testing, but it helped reveal possible E.coli 0157:H7.
Isolation of E. coli 0157:H7: For the isolation of E. coli 0157:H7, the samples

were pooled by pig weight within farms. A lmL aliquot of sample from each pig
of the same weight and farm was thawed at room temperature and combined. One
mL of the pooled sample was placed in 5 mL ofmTSB and incubated at 37° C for
24 hours for enrichment. One mL of enrichment was used in immunomagnetic
separation with Dynabeads® (Dynal, 5 Delaware Drive, Lake Success, NY).
Dynabeads®anti-E. coli 0157 beads are coated with specific antibodies designed
to bind to the target bacteria. The bead-bacteria complexes were magnetically
separated from the suspension, removed with a pipette, and streaked for isolation
on differential agar plates of Sorbitol MacConkey agar (SMAC, BBL, Becton
Dickinson Microbiology Systems, Cockeysville, MD) and MAC II and incubated
at 37° C for 24 hours. One control plate of each medium was streaked with E. coli
0157:H7 ( Jack in the Box strain kindly provided by Dr. Laslo Csonka, Purdue
University). Suspect colonies were colorless on SMAC, as E. coli 0157:H7 do not
24

ferment sorbitol and were pink but glucoronidase negative on MAC II (BAM
1995). Homogenous, typical colonies were tested using Analytical Profile Index
20E (API, bioMerieux Vitek, Inc., Hazelwood, MO). API 20E tests consist of a
series of biochemical tests used to identify Enterobacteriaceae and other Gramnegative bacteria. Presumptive non-sorbitol fermenting E. coli colonies were
identified and assumed to be O157:H7.
Isolation ofSalmonella Typhimurium: For the isolation of Salmonella, the

samples were pooled by pig weight within farms. A lmL aliquot of sample from
each pig of the same weight and farm was thawed at room temperature and
combined. One mL from each pooled mixture was incubated in 5 mL of Brain
Heart Infusion (BHI, Difeo Laboratories, Detroit, MI) and incubated at 37° C for
24 hours to revive cells. In addition, a Salmonella Typhimurium control (ATCC
4232) was incubated in the same way. After incubation, one mL of the BHI
culture was placed in 9 mL of sterile Lactose Broth (LB) for pre-enrichment. LB
contains lactose which non-Salmonella organisms ferment causing the pH to
decrease. After 60 min at room temperature, the pH of the medium was adjusted to
6.8 with sterile 1 N NaOH or 1 N HCL, returning the solution to that which
favored a higher ratio of Salmonella to non-Salmonella organisms (BAM 1995).
The LB cultures were incubated for 24 hours at 35° C. For enrichment, one mL of
the pre-enrichment was transferred into 10 mL ofTetrathionate Broth (TT, Difeo)
and incubated at 42° C for 24 hours. TT broth is a selective media with bile salts
to inhibit Gram-positive organisms. Tetrathionate is formed in the medium by the
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addition of the iodine-iodide solution and inhibits the normal intestinal flora of
fecal specimens (Draughon 1999). One loopful of the enrichment was streaked for
isolation onto Xylose-Lysine-Tergitol 4, Brilliant Green, and Bismuth Sulfite agars
each (XL T4, BG, and BS, Difeo) and incubated for 48 hours at 35° C. These agars
all vary in selectivity and were chosen to increase the chances of recovering as
many Salmonella as possible.
XLT4 is a highly selective media for non-typhi salmonellae. Tergitol 4
supplement inhibits non-Salmonella organisms. This agar contains 3 fermentable
sugars, xylose, sucrose, and lactose. Phenol red serves as a pH indicator to detect
acid (yellow) production from fermentation. When xylose is exhausted,
Salmonella decarboxylate lysine which causes alkaline pH production (red) agar
(Ebner 1999). Sodium thiosulfate (tergitol) and ferric ammonium citrate are
differential hydrogen sulfide indicators that make the Salmonella Typhimurium
colonies black. Black colonies on red medium were selected for further testing,
BG agar contains brilliant green dye that inhibits Gram-positive bacteria and a
majority of Gram-negative bacilli. Phenol red indicates acid production from the
fermentation oflactose or sucrose. Salmonella were characterized by pink-white
colonies on red medium.
BS agar also contains brilliant green dye and bismuth to inhibit Gram-positive
bacteria and many Gram-negative enteric organisms, except most Salmonella and
some Shigella species. Ferrous sulfate is an indicator of hydrogen sulfide
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production. Salmonella were characterized by brown, black, or dark green
colonies that sometimes had a metallic sheen on green medium.
Presumptive colonies were subjected to serological identification using BactoSalmonella 0 , H and Vi antisera (Bacto Salmonella O Antiserum Poly A-I and Vi,
Difeo Laboratories, Detroit, MI). Duplicate samples of these colonies were sent to
another laboratory at the University of Tennessee, Knoxville for type identification
using a random primer PCR DNA fingerprint analysis.

Microdilution Tray Preparation: Eight typical E. coli colonies were randomly
selected and as many S. Typhimurium and presumptive E. coli 0157 colonies as
could be found were transferred into 5 mL of Cation Adjusted Mueller Hinton II
Broth (MH II, BBL). The tubes were incubated in a water bath (Orbit shaker bath,
Lab-line Instruments, Inc., Melrose Park, IL) at 37° C for 30 min. to 2 hours, or
until turbidity of the contents was visibly equal to 0.5 McFarland standard.
(National Committee for Clinical Laboratory Standards 1990). The cultures were
used for minimum inhibitory concentration determination using approved
standards set by the NCCLS . Antibiotics used in the susceptibility tests were
ampicillin (Sigma Chemical Co. , St. Louis, MO), ceftiofur sodium (Naxcel®
Pharmacia & Upjohn Company, Kalamazoo, MI), gentarnicin (ICN Biochemicals,
Inc. , Aurora, OH), oxytetracycline (Oxytetracycline dihydrate, USP, ICN
Biochemicals, Cleveland, OH), and sulfamethazine (Sigma). Veterinarians, pork
producers, and extension agents interviewed reported that these antibiotics were
most commonly used in swine operations. Aqueous stock solutions of these
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antibiotics were made in a ten-fold concentration and stored at -80° C for filling
the microdilution trays as needed (NCCLS 1998). The assay potencies of the
antibiotics were 1000 µg/mg for ampicillin, ceftiofur and sulfamethazine, 998
µg/mg for oxytetracycline, and 595 µg/mg for gentamicin. Sterile water was used

to dissolve the antibiotics except oxytetracycline, which was first dissolved in
absolute ethyl alcohol over heat. Prior to use, stock antibiotic solutions were
thawed and diluted to four-fold concentrations. The wells of sterile microdilution
trays (Costar® styrene, u bottom, 96 well microdilution trays, Corning Inc.,
Corning NY) were first filled with 50 µL ofMH II before adding 50 µL of
antibiotic solutions by way of two-fold serial dilutions. This resulted in 7 rows of
wells, each decreasing in concentration by one-half of the previous row. The
eighth row was left void of antibiotics to serve as a measure of bacteria viability.
Completed trays were sealed with package tape and stored at -80° C.
The trays were thoroughly thawed at room temperature before the addition of
innoculum. Once the bacterial suspension reached the 0.5 McFarland turbidity
standard, 20 µL were diluted in a 1: 10 mixture of sterile, purified water and MH II.
Within 15 minutes, 50 µL were pipetted into each well. The last column of wells
was reserved for the control strain and served as a test for antibiotic dilution
accuracy. The final concentration of bacteria per well was approximately 5 x 10

4

CFU/mL (NCCLS 1990). Minimum inhibitory concentrations were visually
determined using a reflective stand (Microtiter©reading stand, Cooke Engineering
Company, Alexandria, VA). Final dilution ranges of antibiotics from the top row
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of the microdilution trays to the last row are listed on Table 2 along with the
NCCLS established endpoints at which resistance was recorded.

Statistics: Antibiotic resistance, measured by MIC and the number of resistant
isolates for each farm type was determined using General Linear Models analysis
for numerical data. Least squares means by LSD mean separation were used to
compare composite MI Cs from both farm types, the percentage of resistant E. coli
between farm types, and the percentage of resistant E. coli isolated from pigs of
various sizes between farm types. Chi-square analysis :frequency procedure was
conducted to determine differences between farm types using MICs of Salmonella
isolates.
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4. RESULTS
The use or exclusion of antibiotics on farms affected sensitivity and resistance
of swine E. coli. Farms that excluded antibiotics had lower (P < 0.001) MICs for
ampicillin, gentarnicin, oxytetracycline and sulfamethazine. There were no significant
differences between the 2 farm types in sensitivity to ceftiofur although, the composite
MIC for E. coli from antibiotic exclusion farms (A-) was 0.03 µg/mL higher than that
of the antibiotic use farms (A+) (Table 3).
A- farms had lower percentages (P < 0.001) ofresistant E. coli. For each
antibiotic tested, composite MICs from A+ farms were higher (P < 0.05), except for
ceftiofur to which there were no resistant isolates from either farm type (Figure 1).
Otherwise, the percentage of gentamicin resistant E. coli was lowest and the
percentage of oxytetracycline resistant E. coli was greatest among both farm types. Afarms had 0.31 percent gentamicin resistant E. coli and A+ farms had 1.4 percent. The
percentage of oxytetracycline resistant E. coli from these farms was 41 and 86 percent
respectively.
Mean MI Cs only varied among pig sizes on A- farms for ceftiofur,
oxytetracycline and sulfamethazine (Table 4). Variation in MICs between some pigs
of different sizes on A+ farms occurred with all antibiotics except ceftiofur. For both
farm types, when differences did exist, MICs were numerically higher for isolates
from pigs that weighed 23 kg or less. In contrast, the greatest MI Cs among isolates
from A+ farms for oxytetracycline were found in larger pigs. Isolates from 109 kg
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pigs and sows had numerically higher MICs. There were no differences between
MI Cs of isolates from pigs of different sizes for ceftiofur from A+ farms.
The percentages of ampicillin resistant E. coli were only different (P < 0.001) among
pigs of different sizes on A+ farms. The greatest percentages of resistant E. coli were
among pigs less than 45 kg. Market weight pigs (109 kg), 45 kg pigs, and sows had
the fewest ampicillin resistant isolates (Figure 2). The percentage of ampicillin
resistant isolates from market weight pigs of both farm types was not different (P >
0.05).
The percentages of gentamicin resistant E. coli were only different (P < 0.001)
between pigs of different weights on A+ farms. Isolates from pigs less than 23 kg
were higher (P < 0.05) than pigs of greater weights.
Only one weight group of pigs (45 kg) from A- farms had gentamicin resistant
E. coli; however, there were no significant differences between weight groups on these

farms.
The percentage of gentamicin resistant isolates from pigs of 45 and 109 kg
pigs and sows were statistically the same (P > 0.05) for both farm types.
The percent of oxytetracycline resistant E. coli differed among pigs of different
weights of both farm types (P < 0.05).
Among A+ farms, E. coli from pigs 45 kg and less had a lower (P < 0.05)
percentage of oxyteracycline resistance than market weight pigs and sows (Figure 4).
In contrast, the percentage of oxytetracycline resistant E. coli declined as pig age
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increased (P < 0.05) in A- farms and in all age groups the percentage was lower
compared to A+ farms.
The percentage of sulfamethazine resistant E. coli among pigs of various
weights was different (P < 0.001) between both farm types (Figure 5) for all weight
groups except 45 and 109 kg.
The most distinct difference (P < 0.05) among pigs from both farm types were
between pigs that were 23 kg or less and pigs 45 kg or greater. Sows from A- farms
had the lowest percentage (38%) of sulfamethazine resistant E. coli, whereas sows
from A+ farms had percentages ofresistant E. coli that did not differ (P > 0.05) from
those of the 23 and 45 kg pigs of that farm type.
One hundred and thirty-two Salmonella Typhimurium (World Health
Organization nomenclature), O-antigen Type B were isolated from 3 farms. Isolates
originated from all except market weight pigs from two A+ farms, and only from 23
kg pigs of one A- farm.
Chi-square analysis frequency procedure was conducted to determine
differences between farm types using MI Cs of isolates from 23 kg pigs (Figure 6).
Data are represented by 35 isolates from the A+ farms and 11 isolates from the Afarm.
No differences in sensitivity to ampicillin (Chi-square, P
(Chi-square, P

= 0.63), gentamicin

= 0.13), or sulfamethazine (Chi-square, P = 0.40) existed between

farm types. Differences did occur in sensitivity to ceftiofur (P < 0.001) and
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oxytetracycline (P < 0.001). As with E. coli, Salmonella from fanns that excluded
antibiotics were more susceptible to these 2 antibiotics.
All Salmonella isolates from 25 kg pigs on all fanns were susceptible to
ampicillin, ceftiofur, and gentamicin using NCCLS minimum inhibitory
concentrations. One salmonellae from an antibiotic use fann was resistant to
oxytetracycline. All Salmonella isolates were resistant to sulfamethazine (data not
shown).
Twenty-three presumptive E. coli O157:H7 were isolated, but all originated
from fanns that used antibiotics. Thus, comparison of resistance between fann types
was not possible. Eleven of the isolates were from 23 kg pigs on one fann, 10 were
from sows of another and 2 were from 45 kg pigs of yet another fann. The frequency
of antibiotic resistance for each group of isolates were tabulated (Table 5). Of interest,
are the similarities in resistance of isolates from the 2 Indiana fanns that were only 62

km apart.
Even though this was a particularly small data set, the lack of variability in
sensitivity or resistance may be unusual. Isolates were either 100 percent susceptible
or 100 percent resistant to each antibiotic tested.
No E. coli or Salmonella of any kind were detected from pork sample.
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TABLE I. LABEL USE OF ANTIBIOTICS ADMINISTERED ON FARMS THAT USED ANTIBIOTICS 12 MONTHS PRIOR TO TESTING
ANTIBIOTICS USED
npr~uy,m

INDIANA FARM # 2

INDIANA FARM# I

EASTTNFARM
Subtherapeutic use in creep feed

Trade Name: Apralan

oac1uai;;1n

Trade Name: Mecadox

Chlortetracycline
Trade Name: AUREOMYCIN®

w

V,

Lincomycin
Trade Name: Lincomix~

I 09 kg pig feed
Growth promotion use in

Subtherapeutic use in < 34kg

weanling to 14kg pig feed

pig feed

stock as needed

l u-,up~u.J<- ua~

lVI !;IUWmg,

finishing, and breeding stock as
needed

11<01apeuuc

u,.,

m uceeumg

,s01mpreaonc acc1a1e
Trade Name PREDEF®
lsollupredone

77kg pig feed
UJvn·111

ua~

Ill'"!;

lU

11 kg pig feed and therapeutic use

2x per year

in 1-3 day old pigs
Therapeutic use in sows as needed

Therapeutic use in sows as
needed

y,u,m

ug1marnycrn

Subtherapeutic use in 18kg to

stock as needed and in pigs

Growth promotion use in growing and

Trade Name:TYLAN®

Trade Name: Stafac®

uos, auu

needed

Terramycin®

subtherapeutic use in 11 kg to

(depending of gestation status)
l

y1v1ilUUUII auu

18kg pig feed

Therapeutic use in sows as

Many Trade Names:

Trade Name: Procaine Penicillin G

Growth promotion use in nursery feed

subtherapeutic use in all pigs and sows

finishing pigs
Therapeutic use in breeding

UJUnu

UIUn1u .-

Therapeutic use in 40% of

UXJl~uacycune

Penicillin

7kg pig feed
Growth promotion use in 77kg to

Trade Name: BMD

Carbadox

WESTTNFARM
Subtherapeutic use in weanling to

finishing feeds
Growth promotion use and
subtherapeutic use in pig feed
Therapeutic use in sows as
needed

TABLE 2. MINIMUM INHIBITORY CONCENTRATIONS (MIC) AT WHICH
ENTEROBACTERIACEA RESISTANCE IS INDICATED (NCCLS) AND
ANTIBIOTIC CONCENTRATIONS RANGES USED
Antibiotics used in MIC
analyses

NCCLS resistance
concentrations (µg/mL)

Range of antibiotic concentrations
used (µg/mL)
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0-128

~8

0-32

Gentamicin

16

0-128

Oxytetracycline

16

0-128

Sulfamethazine

~256

0-256

Ampicillin
Ceftiofur
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TABLE 3. COMPARISON OF MINIMUM INHIBITORY CONCENTRATIONS OF

E. COLI FROM SWINE FARMS THAT USED OR EXCLUDED ANTIBIOTICS

USING MEAN COMPOSITE MICS

Antibiotic

Type of farm

Mean MIC (µg/mL)

Ampicillin

A+
A-

74.20
13.20

Ceftiofur

A+
A-

0.52
0.55

Gentamicin

A+
A-

4.41 ± 0.33a
2.12 ± 0.34b

Oxytetracycline

A+
A-

217.73 ± 3.43a
105.14 ± 3.53b

Sulfamethazine

A+
A-

316.85 ± 6.43a
190.12 ± 6.57b

±
±
±
±

1

3.25a
3.33b

0.01
0.01

LS mean± SE
a, b superscripts indicate differences between farm types for a given antibiotic (P <
0.05).
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Figure. 1. Percentage of resistant E. coli from farms that used or excluded antibiotics.
Data are Least squares means and represent 1,258 isolates. Bars within antibiotic that
do not share like superscripts differ (P < 0.05). Amp = ampicillin, Gen= gentamicin,
Otc = oxytetracyclin, Sul = sulfamethazine.
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TABLE 4. COMPARISON OF MINIMUM INHIBITORY CONCENTRATIONS
OF E. COL/FROM SWINE OF DIFFERENT WEIGHTS FROM A+ AND AFARMS, USING MEAN MICS (µg/mL)
Pig Weight Groups (kg)
Antibiotic

Ampicillin

Ceftiofur

Gentamicin

Oxytetracycline

Sulfamethazine

4.5

23

45

109

Sows

A+

92.21 b

133.37a

42.17d

37.04de

66.llc

A-

19.02ef

3.91f

g.33f

24.00def

10.74f

A+

0.52b

0.51b

0.52b

0.53b

0.52b

A-

0.67a

0.54b

0.5P

0.50b

0.53b

A+

5.92a

7.41a

3.60b

3.12b

2.00b

A-

2.00b

2.0lb

2.58b

2.oob

2.00b

A+

201.04b

192.51 b

201.33b

250.82a

242.93a

A-

143.83c

144.85c

96.62d

81.75d

58.66e

A+

384.21a

374.47a

290.64b

298.31 b

236.64c

A-

189.24de

226.07cd

264.88bc

172.75e

97.68f

Farm type

A+ = farms that used antibiotics; A-= farms that excluded antibiotics
LS means within antibiotics and not sharing like superscripts differ (P < 0.05)
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Figure. 2. Percentage of ampicillin resistant E. coli between pigs of various weight
groups from farms that used or excluded antibiotics. Data are Least squares means
and represent 1,258 isolates. Bars not sharing like superscripts differ (P < 0.05).
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Figure. 3. Percentage of gentamicin resistant E. coli between pigs of various weight
groups from farms that use or exclude antibiotics. Data are Least squares means and
represent 1,258 isolates. Bars not sharing like superscripts differ (P < 0.05).
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Figure. 4. Percentage of oxytetracycline resistant E. coli between pigs of various
weight groups from farms that used or excluded antibiotics. Data are Least squares
means and represent 1,258 isolates. Bars not sharing like superscripts differ (P <
0.05).
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Figure. 6. Sensitivity to various antibiotics by 46 Salmonella Typhimurium isolates
from 23 kg pigs (pooled by weight) from farms that used or excluded antibiotics.
Asterisks above bars indicate differences between farm types (P < 0.0001). Sensitivity
to sulfamethazine was not different between farms types (P > 0.0001), with MIC's
ranging near 500 µg/mL.
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TABLE 5. PERCENTAGE OF RESISTANT ISOLATES OF 23 POSSIBLE E.

COL/0157:H7

Pooled weights and locations of
i s
23 kg pigs (IN #2)
45 kg pigs (east TN)
Sows (IN #1)

Percentage of resistant isolates

Ceftiofur

23 kg pigs (IN #2)
45 kg pigs (east TN)
Sows (IN #1)

0
0
0

Gentamicin

23 kg pigs (IN #2)
45 kg pigs (east TN)
Sows (IN #1)

0
0
0

Oxytetracycline

23 kg pigs (IN #2)
45 kg pigs (east TN)
Sows (IN #1)

100%
100%
100%

Sulfamethazine

23 kg pigs (IN #2)
45 kg pigs (east TN)
Sows (IN #1)

100%
100%
100%

Antibiotic

Ampicillin

45

100%
0
100%

5. DISCUSSION
Mean MICs for ampicilin, gentamicin, oxytetracyline, and sulfamethazine
were more than twice as high for E.coli from A+ farms compared to A_ farms.
Lack of ceftiofur resistance on either farm type may be attributed to the more recent
incorporation of ceftiofur into animal use, and its infrequent, therapeutic use in
swine.
The A_ farms were intended to represent practical non-selective hog
production environments and serve as a type of control for comparison with A+
farms. Occasionally E.coli isolates from

A_

farms exceeded 2% resistance, which

was Novick' s ( 1981) description of a normal "wild type" population.
Oxytetracycline was the only antibiotic common to the A+ farms. It was
used also used therapeutically to treat sows on two of the A+ farms. Another
tetracycline derivative, chlortetracycline, was used almost continuously on three
out of four A+ farms.
The selective pressure of one or more related or unrelated antibiotics used
on farms may have selected for resistance mechanisms that caused resistance to the
antibiotics analyzed in this study. If so, it is likely that a certain percentage of these
isolates contained multiple resistant mechanisms
The vast differences between farm types might also be explained by
distinctive husbandry practices, other than the use or exclusion of antibiotics. For
example, more intensive farms, (on which antibiotics may be more likely used),
more commonly have confinement buildings.
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The close contact among animals

and limited exposure to external influences might select for resistant bacteria.
Producers that raise hogs without the use of antibiotics are more likely to have free
range or open air type farms that might allow for a more natural balance of resistant
to susceptible bacteria. External factors known to increase antimicrobial-resistant
enteric bacteria, such as described by Embry et al. (1962,1966,1969) Williams and
Newell (1970), Corrier et al. (1990), or Moro et al. (1998), may have affected the
bacterial resistance of each farm type.
An non-statistical analysis of data from the three A_ farms using the mean
MICs was conducted (data not shown). It was found that the percentage of
ampicillin, oxytetracycline and sulfamethazine resistant E.coli differed significantly
between farms. It is likely that more variables other than the presence or absence
of antibiotics should be considered before banning or restricting their use in food
animals. Factors such as poor farm hygiene, questionable feed sources, lax
biosecurity and minimal lot drainage, may be responsible for variances in
occurrence, prevalence and persistence of resistant bacteria.
One important trend regarding the prevalence of resistance among all of the
farms tested was its gradual reduction across increasing pig weights. This
phenomenon has been reported by others (Hays 1969, Langlois 1986, Mathew
1998), but may bear repeating due to its relevance to market weight pigs, which are
ready for human consumption. The one exception to this trend was with
oxytetracycline. Ninety-nine percent of the E. coli from market weight hogs and
96% from sows were resistant to oxytetracycline, whereas only 80% of E. coli from
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the smaller pigs were resistant. High levels of oxytetracycline resistant bacteria
have been encountered in similar research. Upchurch (1995) summarized his
results, and those of others, by pointing out that tetracyclines have been used in
swine feeds for more than three decades in all weight classes of pigs and for both
reproductive and growth enhancement. Sows are usually free of E. coli entering the
farrowing unit but become infected as a result of contact with young offspring in
the farrowing house (Hinton and Linton 1987). Baby pigs' GI tracts may be
rapidly colonized with resistant bacteria because they lack exclusive commensal
flora. Additionally, sows from two of the A+ farms were routinely given
therapeutic doses of oxytetracycline post-farrowing which may have affected our
results. In addition, sows are kept longer than pigs, approximately 3 years in
intensive systems and possibly longer in others. Thus, they might be expected to
contain an accumulation of flora representing the entire farm environment
Differences in percentages of gentamicin and ampicillin resistant E. coli
occurred in our study. However, for A_ farms there were no differences between
the different weight groups. This may be a reflection on the lack of confinement
practices of this type of farm. For instance, these pigs might not have been
segregated as to size or age. In intensive production systems, all-in-all-out is a
common management scheme. Each new pig population is isolated from others
and relocation to larger pens is preceded by stringent sanitation of the new quarters.
Apparently this is an important control point in reducing the amount or spread of
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resistant bacteria. Segregation may be partly responsible for the reduction in
resistance frequency in market weight pigs on A+ farms.
As with oxtytetracycline, the high percentages of sulfamethazine resistant

E. coli from both farm types might be explained by the longevity of sulfanarnides
in the animal health industry. The antibacterial activity of the sulfa drugs started
the antibacterial revolution and has been exploited for over 60 years (Visek 1978).
Of note from these data is the uncommonly low percentage (39%) of
sulfamethazine resistant E. coli isolated from sows of A._ farms. Sample collection
may have occurred following a recent turnover in sow population in one or more of
the A._ farms. Many specialty breeding stock suppliers, such as those that would
supply stock to A._ farms, follow stringent "organic" guidelines which would
reduce the occurrence ofresistant organisms even further. For example, certain
rearing facilities have attained organic status through decades of antibiotic
exclusion and the use of only organically raised feeds.
Zoonotic pathogens, Salmonella Typhimurium and possibly E. coli

0157:H? were isolated from some pigs of every weight group except market
weight pigs. The importance of this observation cannot be fully realized because
there were too few data and a dearth of comparative research.
Most research concerning market weight animals seems to have been at
processing plants prior to or directly after slaughter. As such, data from these
efforts might not represent near market weight populations on farms, as were
sampled in this study. Research has shown that the stresses involved in transport to
49

market increase pathogen load and antimicrobial-resistant enteric bacteria in
animals (Embry et al. 1962,1966,1969).
The S. Typhiumurium isolates apparent sensitivity to all of the antibiotics
tested except sulfamethazine might be attributed to efficient prevention and control
measures on farms. Many of the food additives listed from the A+ farms were
specified for the control and prevention of salmonellosis.
The multidrug resistant (ampicillin, oxytetracycline, sulfamethazine)
presumptive E. coli O 157 :H7 isolates may have been a localized phenonomen.
Twenty-one of23 originated from neighboring farms. E.coli 0157:H? are not
frequently associated with swine or pork products. The frequency of ampicillin
resistant E. coli was less than 37% for both of these farms (data not shown). Thus,
it would seem that these pathogens might have "acquired" resistance to ampicillin
elsewhere before contaminating the two farms in this study.
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6. IMPLICATIONS

Antibiotic resistance transfer from animal to human pathogenic bacteria is
perceived as an eminent threat to human health. Livestock producers must be able
to identify and eradicate practices that contribute to the emergence and spread of
resistant organisms if they expect legislative officials to support their use of
antibiotics on farms. With continued research it is becoming apparent that abrupt
discontinuance of antibiotics does not eliminate resistant bacteria. Exclusion of
antibiotics from the onset of production is simply not a practical alternative for
more than a handful of "niche" market competitors due to the evolution of the food
animal production industry.
Producers that excluded antibiotics in this study were observed to have less
than one half of the percentage of resistant E. coli in their pigs compared to
producers that used antibiotics. However, the presence of high numbers ofresistant

E. coli for the two oldest antibiotics (oxytetracycline and sulfamethazine) among
these farms may indicate that once resistant mechanisms become established they
are not likely to disappear with the removal of selective pressure. Significant
differences between antibiotic exclusion farms in resistance to ampicillin may
imply that other management practices outside of the exclusion of antibiotics
influence resistant bacterial populations. Further research will be necessary to
characterize these confounding factors.
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